Insights On Drug Development

  1. Budgeting Key Component In Biologics Flexibility At CDMOs 6/26/2025

    You want flexibility in scheduling, contracts, and the entire CDMO relationship. While money can't buy you love, it can go a long way in getting that more flexible partnership.

  2. Developing Amorphous Solid Dispersions For Poorly Soluble Drugs 6/20/2025

    Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.

  3. Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development 6/19/2025

    Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

  4. Formulation Development 101: What Is It And Why Does It Matter? 6/16/2025

    Discover why formulation development is a critical, high-stakes process that transforms scientific innovation into safe, effective therapies for patients.

  5. Designing Protocols For A 40% Emulsifiable Concentrate Of A Systemic Insecticide 6/13/2025

    Explore how formulation expertise can help overcome the complex challenges of developing stable, effective, and regulatory-compliant emulsifiable concentrate (EC) formulations for crop protection.

  6. The Role Of Developability In Lead Candidate Selection 6/12/2025

    Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

  7. Modifying The Micro-Environment To Improve Dissolution Rate 6/11/2025

    Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

  8. Deliver What's Next With A Cell Therapy Manufacturing Platform 6/11/2025

    Streamline CAR T cell therapy manufacturing with an end-to-end solution featuring two automated systems that optimize every stage from cell isolation to final therapeutic dose.

  9. Increased Productivity At Commercial Scale 6/11/2025

    Discover how a platform that boosts CAR T therapy manufacturing with advanced automation and modular design reduces labor, increases scalability, and enhances productivity for efficient commercial-scale production.

  10. Formulation Development For Therapeutic Oligonucleotides 6/10/2025

    Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.